OMEROS

pharmaceuticals, namely surgical and burn management solutions containing pharmacologic agents for the inhibition of pain, inflammation, cartilage loss, smooth muscle spasm and tumor cell adhesion; intravascular solutions containing pharmacologic agents for the inhibition of vasospasm and restenosis; drug delivery systems, namely combinations of pharmacologic agents or genes and their carriers for the treatment and inhibition of pain, inflammation, cartilage loss, smooth muscle spasm, tumor cell adhesion, vasospasm and restenosis

medical apparatus, namely devices for the repair of tendons, ligaments and nerves